{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:56:11Z","timestamp":1792425371130,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lifestyle and physiological variables on human disease risk have been revealed to be mediated by gut microbiota. Low concordance between case-control studies for detecting disease-associated microbe existed due to limited sample size and population-wide bias in lifestyle and physiological variables. To infer gut microbiota-disease associations accurately, we propose to build machine learning models by including both human variables and gut microbiota. When the model\u2019s performance with both gut microbiota and human variables is better than the model with just human variables, the independent gut microbiota -disease associations will be confirmed. By building models on the American Gut Project dataset, we found that gut microbiota showed distinct association strengths with different diseases. Adding gut microbiota into human variables enhanced the classification performance of IBD significantly; independent associations between occurrence information of gut microbiota and irritable bowel syndrome,\n                    <jats:italic>C. difficile<\/jats:italic>\n                    infection, and unhealthy status were found; adding gut microbiota showed no improvement on models\u2019 performance for diabetes, small intestinal bacterial overgrowth, lactose intolerance, cardiovascular disease. Our results suggested that although gut microbiota was reported to be associated with many diseases, a considerable proportion of these associations may be very weak. We proposed a list of microbes as biomarkers to classify IBD and unhealthy status. Further functional investigations of these microbes will improve understanding of the molecular mechanism of human diseases.\n                  <\/jats:p>","DOI":"10.1186\/s12866-021-02414-9","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T04:05:28Z","timestamp":1641182728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors"],"prefix":"10.1186","volume":"22","author":[{"given":"Congmin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"2414_CR1","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1128\/AEM.65.11.4799-4807.1999","volume":"65","author":"A Suau","year":"1999","unstructured":"Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999;65:4799\u2013807.","journal-title":"Appl Environ Microbiol"},{"key":"2414_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36:305\u201312.","journal-title":"Trends Neurosci"},{"key":"2414_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1126\/science.aad9948","volume":"352","author":"H Chu","year":"2016","unstructured":"Chu H, Khosravi A, Kusumawardhani IP, Kwon AH, Vasconcelos AC, Cunha LD, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science (New York, NY). 2016;352:1116\u201320.","journal-title":"Science (New York, NY)"},{"key":"2414_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejim.2018.02.006","volume":"50","author":"M Samarkos","year":"2018","unstructured":"Samarkos M, Mastrogianni E, Kampouropoulou O. The role of gut microbiota in Clostridium difficile infection. Eur J Intern Med. 2018;50:28\u201332.","journal-title":"Eur J Intern Med"},{"key":"2414_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376\u201381.","journal-title":"Nature"},{"key":"2414_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:845.","journal-title":"Nat Commun"},{"key":"2414_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","volume":"17","author":"TR Sampson","year":"2015","unstructured":"Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015;17:565\u201376.","journal-title":"Cell Host Microbe"},{"key":"2414_CR8","doi-asserted-by":"crossref","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19:55\u201371.","DOI":"10.1038\/s41579-020-0433-9"},{"key":"2414_CR9","first-page":"611","volume":"27","author":"X Hao","year":"2011","unstructured":"Hao X, Jiang R, Chen T. Clustering 16S rRNA for OTU prediction: a method of unsupervised Bayesian clustering. Bioinformatics (Oxford, England). 2011;27:611\u20138.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"2414_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1017\/S0007114509993400","volume":"103","author":"R Oozeer","year":"2010","unstructured":"Oozeer R, Rescigno M, Ross RP, Knol J, Blaut M, Khlebnikov A, et al. Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br J Nutr. 2010;103:1539\u201344.","journal-title":"Br J Nutr"},{"key":"2414_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0565-6","volume":"6","author":"J Tackmann","year":"2018","unstructured":"Tackmann J, Arora N, Schmidt TSB, Rodrigues JFM, von Mering C. Ecologically informed microbial biomarkers and accurate classification of mixed and unmixed samples in an extensive cross-study of human body sites. Microbiome. 2018;6:1\u201316.","journal-title":"Microbiome"},{"key":"2414_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-019-0091-8","volume":"5","author":"MA Stanislawski","year":"2019","unstructured":"Stanislawski MA, Dabelea D, Lange LA, Wagner BD, Lozupone CA. Gut microbiota phenotypes of obesity. NPJ Biofilms Microbiomes. 2019;5:1\u20139.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2414_CR13","doi-asserted-by":"publisher","first-page":"e01018","DOI":"10.1128\/mBio.01018-16","volume":"7","author":"MA Sze","year":"2016","unstructured":"Sze MA, Schloss PD. Looking for a signal in the noise: revisiting obesity and the microbiome. MBio. 2016;7:e01018\u20136.","journal-title":"MBio"},{"key":"2414_CR14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/gutjnl-2019-318717","volume":"69","author":"LW Hugerth","year":"2020","unstructured":"Hugerth LW, Andreasson A, Talley NJ, Forsberg AM, Kjellstr\u00f6m L, Schmidt PT, et al. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut. 2020;69:1076\u201384.","journal-title":"Gut"},{"key":"2414_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18871-1","volume":"11","author":"O Manor","year":"2020","unstructured":"Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11:1\u201312.","journal-title":"Nat Commun"},{"key":"2414_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2016.12.012","volume":"4","author":"Y Yang","year":"2017","unstructured":"Yang Y, Chen N, Chen T. Inference of environmental factor-microbe and microbe-microbe associations from metagenomic data using a hierarchical Bayesian statistical model. Cell Syst. 2017;4:129\u201337.e5.","journal-title":"Cell Syst"},{"key":"2414_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-015-0117-2","volume":"3","author":"D Mcdonald","year":"2015","unstructured":"Mcdonald D, Birmingham A, Knight R. Context and the human microbiome. Microbiome. 2015;3:1\u20138.","journal-title":"Microbiome"},{"key":"2414_CR18","doi-asserted-by":"publisher","first-page":"e1004977","DOI":"10.1371\/journal.pcbi.1004977","volume":"12","author":"E Pasolli","year":"2016","unstructured":"Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput Biol. 2016;12:e1004977.","journal-title":"PLoS Comput Biol"},{"key":"2414_CR19","doi-asserted-by":"publisher","unstructured":"Tierney BT, He Y, Church GM, Segal EJ, Kostic AD, Patel CJ. The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2019.12.31.891978.","DOI":"10.1101\/2019.12.31.891978"},{"key":"2414_CR20","doi-asserted-by":"publisher","unstructured":"Salosensaari A, Laitinen V, Havulinna AS, Meric G, Cheng S, Perola M, et al. Taxonomic signatures of long-term mortality risk in human gut microbiota. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2019.12.30.19015842.","DOI":"10.1101\/2019.12.30.19015842"},{"key":"2414_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/pathogens8030126","volume":"8","author":"I Khan","year":"2019","unstructured":"Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, et al. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8:126.","journal-title":"Pathogens"},{"key":"2414_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11938-019-00221-w","volume":"17","author":"NC Knox","year":"2019","unstructured":"Knox NC, Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiome as a target for IBD treatment: are we there yet? Curr Treat Options Gastroenterol. 2019;17:115\u201326.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"2414_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40168-017-0260-z","volume":"5","author":"JS Labus","year":"2017","unstructured":"Labus JS, Hollister EB, Jacobs J, Kirbach K, Oezguen N, Gupta A, et al. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome. 2017;5:49.","journal-title":"Microbiome"},{"key":"2414_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10620-012-2033-7","volume":"57","author":"E Pyleris","year":"2012","unstructured":"Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012;57:1321\u20139.","journal-title":"Dig Dis Sci"},{"key":"2414_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655\u201362.","journal-title":"Nature"},{"key":"2414_CR26","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2414_CR27","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s10620-015-3765-y","volume":"60","author":"I Zollner-Schwetz","year":"2015","unstructured":"Zollner-Schwetz I, Herzog KA, Feierl G, Leitner E, Schneditz G, Sprenger H, et al. The toxin-producing pathobiont Klebsiella oxytoca is not associated with flares of inflammatory bowel diseases. Dig Dis Sci. 2015;60:3393\u20138.","journal-title":"Dig Dis Sci"},{"key":"2414_CR28","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1053\/j.gastro.2011.06.072","volume":"141","author":"DM Saulnier","year":"2011","unstructured":"Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011;141:1782\u201391.","journal-title":"Gastroenterology"},{"key":"2414_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ismej.2010.92","volume":"5","author":"A Giongo","year":"2011","unstructured":"Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82\u201391.","journal-title":"ISME J"},{"key":"2414_CR30","doi-asserted-by":"publisher","first-page":"e25792","DOI":"10.1371\/journal.pone.0025792","volume":"6","author":"CT Brown","year":"2011","unstructured":"Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;6:e25792.","journal-title":"PLoS One"},{"key":"2414_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407\u201315.","journal-title":"N Engl J Med"},{"key":"2414_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology (Baltimore, Md). 2011;54:562\u201372.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"2414_CR33","doi-asserted-by":"publisher","first-page":"e16393","DOI":"10.1371\/journal.pone.0016393","volume":"6","author":"I Sobhani","year":"2011","unstructured":"Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011;6:e16393.","journal-title":"PLoS One"},{"key":"2414_CR34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ismej.2008.37","volume":"2","author":"J Dicksved","year":"2008","unstructured":"Dicksved J, Halfvarson J, Rosenquist M, J\u00e4rnerot G, Tysk C, Apajalahti J, et al. Molecular analysis of the gut microbiota of identical twins with Crohn\u2019s disease. ISME J. 2008;2:716\u201327.","journal-title":"ISME J"},{"key":"2414_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C Manichanh","year":"2006","unstructured":"Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach. Gut. 2006;55:205\u201311.","journal-title":"Gut"},{"key":"2414_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.MIB.0000200323.38139.c6","volume":"12","author":"H Sokol","year":"2006","unstructured":"Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:106\u201311.","journal-title":"Inflamm Bowel Dis"},{"key":"2414_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59\u201364.","journal-title":"Nature"},{"key":"2414_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/JCP.0000000000000812","volume":"38","author":"K van Keulen","year":"2018","unstructured":"van Keulen K, Knol W, Schrijver EJM, van Marum RJ, van Strien AM, Nanayakkara PWB. Prophylactic use of haloperidol and changes in glucose levels in hospitalized older patients. J Clin Psychopharmacol. 2018;38:51\u20134.","journal-title":"J Clin Psychopharmacol"},{"key":"2414_CR39","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3748\/wjg.v23.i21.3771","volume":"23","author":"A Cozma-Petru\u0163","year":"2017","unstructured":"Cozma-Petru\u0163 A, Loghin F, Miere D, Dumitra\u015fcu DL. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients! World J Gastroenterol. 2017;23:3771\u201383.","journal-title":"World J Gastroenterol"},{"key":"2414_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","volume":"590","author":"J Aguilera-Lizarraga","year":"2021","unstructured":"Aguilera-Lizarraga J, Florens MV, Viola MF, Jain P, Decraecker L, Appeltans I, et al. Local immune response to food antigens drives meal-induced abdominal pain. Nature. 2021;590:151\u20136.","journal-title":"Nature"},{"key":"2414_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simr\u00e9n","year":"2013","unstructured":"Simr\u00e9n M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62:159\u201376.","journal-title":"Gut"},{"key":"2414_CR42","first-page":"351","volume":"68","author":"M Simpson","year":"2019","unstructured":"Simpson M, Lyon C. PURL: do probiotics reduce C diff risk in hospitalized patients? J Fam Pract. 2019;68:351 2;4.","journal-title":"J Fam Pract"},{"key":"2414_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2036.2007.03557.x","volume":"27","author":"MC Lomer","year":"2008","unstructured":"Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther. 2008;27:93\u2013103.","journal-title":"Aliment Pharmacol Ther"},{"key":"2414_CR44","doi-asserted-by":"publisher","unstructured":"Lind L, Ingelsson E, Sundstr\u00f6m J, Siegbahn A, Lampa E. Methylation-based estimated biological age and cardiovascular disease. Eur J Clin Investig. 2018;48. https:\/\/doi.org\/10.1111\/eci.12872.","DOI":"10.1111\/eci.12872"},{"key":"2414_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2015.04.806","volume":"241","author":"JD Spence","year":"2015","unstructured":"Spence JD, Pilote L. Importance of sex and gender in atherosclerosis and cardiovascular disease. Atherosclerosis. 2015;241:208\u201310.","journal-title":"Atherosclerosis"},{"key":"2414_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fmicb.2016.00455","volume":"7","author":"A Mosca","year":"2016","unstructured":"Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front Microbiol. 2016;7:455.","journal-title":"Front Microbiol"},{"key":"2414_CR47","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1080\/19490976.2020.1778261","volume":"11","author":"C Menni","year":"2020","unstructured":"Menni C, Zhu J, Le Roy CI, Mompeo O, Young K, Rebholz CM, et al. Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes. Gut Microbes. 2020;11:1632\u201342.","journal-title":"Gut Microbes"},{"key":"2414_CR48","first-page":"3211","volume":"28","author":"E Kopylova","year":"2012","unstructured":"Kopylova E, No\u00e9 L, Touzet H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics (Oxford, England). 2012;28:3211\u20137.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"2414_CR49","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ Desantis","year":"2006","unstructured":"Desantis TZ, Hugenholtz P, ., Larsen N, ., Rojas M, ., Brodie EL, Keller K, ., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72:5069-5072.","journal-title":"Appl Environ Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02414-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-021-02414-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02414-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T08:09:01Z","timestamp":1676102941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-021-02414-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2414"],"URL":"https:\/\/doi.org\/10.1186\/s12866-021-02414-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}